MIRUM PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$85.00
-1.61%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+1.3%
3 months
-18.7%
6 months
-11.9%
1 year
+17.7%
Year to date
+7.6%
52-week range
$64.10 – $128.57
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$5.52B
P/E
-6.4
P/B
-529.6
P/S
8.9
Revenue
$618.07M
Net income
-$860.21M
Diluted EPS
-14.56
Gross margin
81.70%
Net margin
-139.20%
Return on equity
-410.20%
Total debt
$760.54M
Cash
$332.46M
Free cash flow
-$228.74M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $176.24M | -$67.23M | 82.80% | -38.10% | -$44.28M |
| Mar 31, 2026 | $159.88M | -$790.16M | 82.00% | -494.20% | -$229.43M |
| Dec 31, 2025 | $148.93M | -$5.73M | 81.00% | -3.80% | $5.47M |
| Sep 30, 2025 | $133.01M | $2.91M | 80.80% | 2.20% | $39.49M |
| Jun 30, 2025 | $127.79M | -$5.86M | 81.70% | -4.60% | $11.91M |
| Mar 31, 2025 | $111.59M | -$14.68M | 79.40% | -13.20% | -$2M |
| Dec 31, 2024 | $99.41M | -$23.79M | 77.10% | -23.90% | -$5.09M |
| Sep 30, 2024 | $90.38M | -$14.24M | 77.00% | -15.80% | $3.8M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MIRM news
All market newsNo ticker-linked stories are in the current archive.